Academic Article RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial.
• 5-Fluorouracil in the treatment of scleroderma: A randomised, double blind, placebo controlled international collaborative study
• 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein
• 5-Phenylthioacyclouridine: A potent and specific inhibitor of uridine phosphorylase
• 5.43 ARE ASD APPS INVASIVE?
• 50 Years Ago in THE JOURNAL OF PEDIATRICS: Diarrheagenic Escherichia coli: Enduring and Evolving
• 50 years of the International Committee on Taxonomy of Viruses: progress and prospects
• 50 years of the International Committee on Taxonomy of Viruses: progress and prospects
• 51st Annual Meeting of the Society of Gynecologic Oncology
• 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions
• 58. Angiogenesis development during the progression of human astrocytoma
• 6 calcium imaging in macula densa cells
• 6 Months of "Temporary" Support by Levitronix Left Ventricular Assist Device
• 6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities
• 6-Benzylthioinosine analogues: Promising anti-toxoplasmic agents as inhibitors of the mammalian nucleoside transporter ENT1 (es)
• 6-Mercaptopurine augments glucose transport activity in skeletal muscle cells in part via a mechanism dependent upon orphan nuclear receptor NR4A3
• 6-Methylpurine derived sugar modified nucleosides: Synthesis and evaluation of their substrate activity with purine nucleoside phosphorylases
• 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase
• 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure
• 6-Oxo and 6-thio purine analogs as antimycobacterial agents
• 60 Gy isodose volumes in carcinoma of the cervix and their relation to the geometry of uterine tube and ovoids.
• 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
• 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.
• 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
• 699: Disparities in postpartum glucose tolerance testing in women with gestational diabetes
• 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: A Children's Oncology Group study
• 6xHis promotes binding of a recombinant protein to heparan sulfate
• 7-azido-actinomycin d: A photoaffinity probe of the sequence specificity of DNA binding by actinomycin d
• 7-Azidoactinomycin D: A novel probe for examining actinomycin D-DNA interactions
• 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...